ZA914709B - Pharmaceutical combination preparations containing cephalosporin and xanthine derivatives and their use - Google Patents

Pharmaceutical combination preparations containing cephalosporin and xanthine derivatives and their use

Info

Publication number
ZA914709B
ZA914709B ZA914709A ZA914709A ZA914709B ZA 914709 B ZA914709 B ZA 914709B ZA 914709 A ZA914709 A ZA 914709A ZA 914709 A ZA914709 A ZA 914709A ZA 914709 B ZA914709 B ZA 914709B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical combination
preparations containing
xanthine derivatives
combination preparations
containing cephalosporin
Prior art date
Application number
ZA914709A
Other languages
English (en)
Inventor
Norbert Klesel
Klesel Norbert
Michael Limbert
Limbert Michael
Elmar Schrinner
Schrinner Elmar
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA914709B publication Critical patent/ZA914709B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA914709A 1990-06-20 1991-06-19 Pharmaceutical combination preparations containing cephalosporin and xanthine derivatives and their use ZA914709B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4019571A DE4019571A1 (de) 1990-06-20 1990-06-20 Pharmazeutische kombinationspraeparate enthaltend cephalosporin- und xanthinderivate und deren verwendung

Publications (1)

Publication Number Publication Date
ZA914709B true ZA914709B (en) 1992-03-25

Family

ID=6408686

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA914709A ZA914709B (en) 1990-06-20 1991-06-19 Pharmaceutical combination preparations containing cephalosporin and xanthine derivatives and their use

Country Status (26)

Country Link
US (1) US5350753A (xx)
EP (1) EP0462506B1 (xx)
JP (1) JP3213339B2 (xx)
KR (1) KR100205161B1 (xx)
CN (1) CN1057390A (xx)
AT (1) ATE144901T1 (xx)
AU (1) AU643291B2 (xx)
BR (1) BR9102554A (xx)
CA (1) CA2044977A1 (xx)
CZ (1) CZ282285B6 (xx)
DE (2) DE4019571A1 (xx)
DK (1) DK0462506T3 (xx)
ES (1) ES2093656T3 (xx)
FI (1) FI912968A (xx)
GR (1) GR3021568T3 (xx)
HR (1) HRP940708B1 (xx)
HU (1) HU212937B (xx)
IE (1) IE76290B1 (xx)
IL (1) IL98535A (xx)
MX (1) MX26309A (xx)
NO (1) NO912382L (xx)
NZ (1) NZ238580A (xx)
PT (1) PT98028B (xx)
RU (1) RU2095063C1 (xx)
YU (1) YU48415B (xx)
ZA (1) ZA914709B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013075A1 (en) * 1993-11-12 1995-05-18 Cell Therapeutics, Inc. Method for preventing tissue injury from hypoxia
ATE226583T1 (de) * 1996-06-07 2002-11-15 Hoechst Ag Verwendung von theophyllinderivaten zur behandlung und propylaxe von schockzuständen, neue xanthinverbindungen und verfahren zu deren herstellung
ATE540129T1 (de) * 2002-11-22 2012-01-15 Univ Johns Hopkins Target zur therapie kognitiver behinderungen
KR101315483B1 (ko) 2011-06-23 2013-10-07 주식회사 아리바이오 항생제 및 라이소포스파티딜콜린을 포함하는 면역 증강 또는 세균성 감염 질환 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel

Also Published As

Publication number Publication date
JP3213339B2 (ja) 2001-10-02
CS187891A3 (en) 1992-02-19
KR100205161B1 (ko) 1999-07-01
FI912968A0 (fi) 1991-06-18
DE4019571A1 (de) 1992-01-02
RU2095063C1 (ru) 1997-11-10
GR3021568T3 (en) 1997-02-28
HRP940708A2 (en) 1997-02-28
JPH04230219A (ja) 1992-08-19
DE59108321D1 (de) 1996-12-12
EP0462506A1 (de) 1991-12-27
AU7848291A (en) 1992-01-02
MX26309A (es) 1994-02-28
IE912107A1 (en) 1992-01-01
BR9102554A (pt) 1992-01-21
IE76290B1 (en) 1997-10-08
NO912382D0 (no) 1991-06-19
YU108291A (sh) 1995-03-27
FI912968A (fi) 1991-12-21
PT98028A (pt) 1992-03-31
KR920000322A (ko) 1992-01-29
CZ282285B6 (cs) 1997-06-11
DK0462506T3 (da) 1996-11-25
NO912382L (no) 1991-12-23
CN1057390A (zh) 1992-01-01
IL98535A0 (en) 1992-07-15
ES2093656T3 (es) 1997-01-01
IL98535A (en) 1996-01-19
CA2044977A1 (en) 1991-12-21
AU643291B2 (en) 1993-11-11
HRP940708B1 (en) 1998-12-31
US5350753A (en) 1994-09-27
HU212937B (en) 1996-12-30
YU48415B (sh) 1998-07-10
EP0462506B1 (de) 1996-11-06
NZ238580A (en) 1993-10-26
HUT57986A (en) 1992-01-28
PT98028B (pt) 1998-11-30
ATE144901T1 (de) 1996-11-15
HU912048D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
IL106842A0 (en) The use of the il-4 receptor for the therapy,prophylaxis and diagnosis of allergic,viral,parasitic and bacterial diseases and of fungal infections
NZ224129A (en) Cephalosporin derivatives and pharmaceutical compositions
HU912013D0 (en) Process for the production of benzopyrane derivatives and their heterocyclic analogues, antiyschemic medical preparations
ZA914709B (en) Pharmaceutical combination preparations containing cephalosporin and xanthine derivatives and their use
IL111338A0 (en) Pharmaceutical or veterinary compositions comprising flavin derivatives for the treatment of viral infections and their preparation
NZ224130A (en) Cephalosporin derivatives and pharmaceutical compositions
IL97734A0 (en) Benzoxazine derivatives,process for their preparation and their use for treatment or for the prophylaxis of diseases
NZ225383A (en) Cephalosporin derivatives and pharmaceutical compositions
IL82767A0 (en) Pharmaceutical formulation comprising a cephem and a penem derivative for the treatment of bacterial infections
IL100407A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
AU1938192A (en) New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives
AU4023889A (en) Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases
NZ224997A (en) Cephalosporin derivatives and pharmaceutical compositions
MY101875A (en) Lankacidin derivatives and production thereof.
GR3021531T3 (en) Cephalosporinderivatives and process for their preparation
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
JPS5692892A (en) Penicillin and cephalosporin derivatives* their manufacture and bacteria infection remedy as effective component thereof
NZ221951A (en) Substituted cephalosporin derivatives and pharmaceutical compositions